Evelo Biosciences (EVLO) Expected to Announce Quarterly Earnings on Monday

Evelo Biosciences (NASDAQ:EVLO – Get Free Report) will likely be announcing its resultson Monday, August 10th. Analysts expect the company to announce earnings of ($10.1333) per share for the quarter.

Evelo Biosciences Price Performance

Evelo Biosciences stock traded up $0.00 during trading hours on Monday, hitting $0.00. Evelo Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.00. The stock has a market capitalization of $5,652.00, a price-to-earnings ratio of -0.00 and a beta of 1.78.

Evelo Biosciences Company Profile

(Get Free Report)

Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.

The company’s pipeline spans inflammatory, autoimmune and oncology indications.

Further Reading

• Five stocks we like better than Evelo Biosciences
• Large Caps Across Planes, Tech and Oil Announce Over $10 Billion in Buybacks
• A Sweet Beat and a Wearables Rally Came With Reasons to Pause
• 3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles
• 3 Humanoid Robot ETFs to Ride a Speculative Trend